Complete Filing Data
ENvue Medical, Inc. reported Stockholders Equity of $3.23 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ENvue Medical, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $2.6M | $2.3M | $752.0K | $1.7M | $623.0K | $530.0K | $318.0K | $239.0K | $229.0K | $147.0K | $203.0K |
| Net Income Loss | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.2M | -$5.0M | -$2.8M | -$2.9M | -$2.6M |
| Selling And Marketing Expense | $720.0K | $864.0K | $965.0K | $1.1M | $993.0K | $1.1M | $1.2M | $465.0K | $514.0K | $377.0K | $301.0K |
| Research And Development Expense | $909.0K | $185.0K | $283.0K | $293.0K | $171.0K | $514.0K | $614.0K | $693.0K | $584.0K | $399.0K | $431.0K |
| Operating Income Loss | -$3.6M | -$3.4M | -$5.0M | -$5.7M | -$4.7M | -$5.2M | -$4.3M | -$3.1M | -$2.3M | -$1.4M | -$1.2M |
| Operating Expenses | $5.1M | $5.0M | $5.2M | $6.5M | $4.9M | $5.4M | $4.5M | $3.2M | $2.5M | $1.5M | $1.3M |
| Income Tax Expense Benefit | $19.0K | $29.0K | $35.0K | $32.0K | $15.0K | -$17.0K | -$127.0K | $38.0K | $117.0K | $28.0K | $49.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.3M | -$4.9M | -$2.7M | -$2.9M | -$2.6M |
| Gross Profit | $1.5M | $1.5M | $167.0K | $770.0K | $214.0K | $281.0K | $160.0K | $151.0K | $141.0K | $98.0K | $110.0K |
| General And Administrative Expense | $3.5M | $3.9M | $3.9M | $5.1M | $3.8M | $3.8M | $2.6M | $2.1M | $1.4M | $746.0K | $589.0K |
| Cost Of Revenue | $1.1M | $746.0K | $585.0K | $925.0K | $409.0K | $249.0K | $158.0K | $88.0K | $88.0K | $49.0K | $93.0K |
| Comprehensive Income Net Of Tax | -$3.7M | -$3.8M | -$5.5M | -$14.3M | -$5.8M | -$2.8M | -$2.9M | -$2.6M | |||
| Net Income Loss Available To Common Stockholders Basic | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.2M | -$5.8M | |||
| Other Nonoperating Expense | $22.0K | $1.8M | $398.0K | $1.4M | $1.4M | ||||||
| Interest Expense | $135.0K | $135.0K | $347.0K | $147.0K | $15.0K | ||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$5.0M | -$2.8M | -$2.9M | -$2.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $722.0K | $494.0K | $1.0M | $376.0K | $817.0K | $921.0K | $458.0K | $294.0K | $354.0K | $97.0K | $485.0K | $272.0K | $499.0K | $318.0K | $103.0K | $150.0K | $269.0K | $114.0K | $101.0K | $263.0K | $79.0K | $54.0K | $132.0K | $77.0K | $65.0K | $52.0K | $52.0K | $61.0K | $62.0K | $57.0K | $40.0K | $39.0K | $29.0K | $25.0K | $64.0K |
| Net Income Loss | $510.0K | -$4.0M | -$2.5M | -$998.0K | -$688.0K | -$588.0K | -$727.0K | -$1.1M | -$1.1M | -$955.0K | -$1.3M | -$1.1M | -$6.7M | -$216.0K | -$4.9M | -$922.0K | -$1.5M | -$921.0K | -$815.0K | -$1.1M | -$2.7M | -$1.3M | -$824.0K | -$789.0K | -$1.6M | -$849.0K | -$877.0K | -$606.0K | -$610.0K | -$495.0K | -$1.0M | -$434.0K | -$630.0K | -$766.0K | -$578.0K |
| Selling And Marketing Expense | $812.0K | $717.0K | $349.0K | $181.0K | $199.0K | $165.0K | $190.0K | $227.0K | $214.0K | $217.0K | $333.0K | $210.0K | $245.0K | $296.0K | $311.0K | $289.0K | $180.0K | $254.0K | $228.0K | $271.0K | $321.0K | $345.0K | $297.0K | $229.0K | $109.0K | $106.0K | $94.0K | $120.0K | $126.0K | $145.0K | $73.0K | $25.0K | $109.0K | $142.0K | $67.0K |
| Research And Development Expense | $221.0K | $972.0K | $530.0K | $249.0K | $187.0K | $121.0K | $33.0K | $35.0K | $55.0K | $49.0K | $61.0K | $66.0K | $50.0K | $64.0K | $64.0K | $68.0K | $16.0K | $47.0K | $79.0K | $150.0K | $152.0K | $121.0K | $151.0K | $136.0K | $160.0K | $164.0K | $150.0K | $161.0K | $173.0K | $114.0K | $87.0K | $115.0K | $95.0K | $101.0K | $89.0K |
| Operating Income Loss | -$2.2M | -$4.0M | -$1.9M | -$970.0K | -$674.0K | -$568.0K | -$670.0K | -$1.0M | -$1.1M | -$924.0K | -$1.3M | -$1.1M | -$868.0K | -$991.0K | -$1.3M | -$804.0K | -$1.5M | -$907.0K | -$793.0K | -$896.0K | -$2.2M | -$1.3M | -$825.0K | -$790.0K | -$613.0K | -$660.0K | -$802.0K | -$545.0K | -$456.0K | -$474.0K | -$338.0K | -$315.0K | -$311.0K | -$518.0K | -$268.0K |
| Operating Expenses | $2.4M | $3.9M | $2.2M | $1.1M | $1.1M | $1.2M | $1.0M | $1.2M | $1.3M | $1.0M | $1.5M | $1.2M | $1.1M | $1.2M | $1.4M | $903.0K | $1.5M | $958.0K | $840.0K | $1.1M | $2.3M | $1.3M | $902.0K | $845.0K | $656.0K | $694.0K | $838.0K | $579.0K | $496.0K | $504.0K | $368.0K | $339.0K | $330.0K | $508.0K | $307.0K |
| Income Tax Expense Benefit | $35.0K | $62.0K | $15.0K | $3.0K | $4.0K | $7.0K | $3.0K | $13.0K | $2.0K | $15.0K | $16.0K | $7.0K | $70.0K | -$4.0K | $21.0K | -$20.0K | $4.0K | $9.0K | $2.0K | $6.0K | $12.0K | $11.0K | $10.0K | $12.0K | $11.0K | $11.0K | $11.0K | $9.0K | $10.0K | $9.0K | $18.0K | $5.0K | $4.0K | $1.0K | $10.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $545.0K | -$3.9M | -$2.5M | -$995.0K | -$684.0K | -$581.0K | -$724.0K | -$1.1M | -$1.1M | -$940.0K | -$1.3M | -$1.1M | -$6.6M | -$220.0K | -$4.9M | -$942.0K | -$1.5M | -$912.0K | -$813.0K | -$1.1M | -$2.7M | -$1.3M | -$814.0K | -$777.0K | -$1.6M | -$838.0K | -$866.0K | -$597.0K | -$600.0K | -$486.0K | -$1.0M | -$429.0K | -$626.0K | -$765.0K | -$568.0K |
| Gross Profit | $189.0K | -$35.0K | $369.0K | $133.0K | $428.0K | $664.0K | $349.0K | $216.0K | $235.0K | $80.0K | $281.0K | $106.0K | $228.0K | $208.0K | $77.0K | $99.0K | $38.0K | $51.0K | $47.0K | $207.0K | $53.0K | $8.0K | $77.0K | $55.0K | $43.0K | $34.0K | $36.0K | $34.0K | $40.0K | $30.0K | $30.0K | $24.0K | $19.0K | -$10.0K | $39.0K |
| General And Administrative Expense | $1.4M | $2.3M | $1.3M | $673.0K | $716.0K | $946.0K | $796.0K | $963.0K | $1.0M | $738.0K | $1.2M | $942.0K | $801.0K | $839.0K | $1.0M | $546.0K | $1.3M | $657.0K | $533.0K | $682.0K | $1.8M | $868.0K | $454.0K | $480.0K | $387.0K | $424.0K | $593.0K | $298.0K | $197.0K | $245.0K | $208.0K | $199.0K | $126.0K | $265.0K | $151.0K |
| Cost Of Revenue | $533.0K | $529.0K | $656.0K | $243.0K | $389.0K | $257.0K | $109.0K | $78.0K | $119.0K | $17.0K | $204.0K | $166.0K | $271.0K | $110.0K | $26.0K | $51.0K | $231.0K | $63.0K | $54.0K | $56.0K | $26.0K | $46.0K | $55.0K | $22.0K | $22.0K | $18.0K | $16.0K | $27.0K | $22.0K | $27.0K | $10.0K | $15.0K | $10.0K | $35.0K | $25.0K |
| Comprehensive Income Net Of Tax | $508.0K | -$4.0M | -$2.5M | -$1.0M | -$691.0K | -$587.0K | -$726.0K | -$1.1M | -$1.1M | -$961.0K | -$1.3M | -$1.1M | -$1.3M | -$824.0K | -$789.0K | -$1.6M | -$849.0K | -$1.7M | -$606.0K | -$610.0K | -$495.0K | -$1.0M | -$434.0K | -$630.0K | -$766.0K | -$578.0K | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$780.0K | -$500.0K | -$2.5M | -$998.0K | -$688.0K | -$588.0K | -$727.0K | -$1.1M | -$1.1M | -$955.0K | -$1.3M | -$1.1M | -$6.7M | -$230.0K | -$4.9M | -$922.0K | -$1.5M | -$921.0K | |||||||||||||||||
| Other Nonoperating Expense | $7.0K | -$11.0K | -$13.0K | $975.0K | $178.0K | $64.0K | $52.0K | $144.0K | $12.0K | $683.0K | $114.0K | $315.0K | $247.0K | $300.0K | |||||||||||||||||||||
| Interest Expense | $144.0K | $53.0K | $33.0K | $34.0K | $34.0K | $35.0K | $33.0K | $34.0K | $123.0K | $7.0K | |||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$789.0K | -$877.0K | -$495.0K | -$630.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $3.2M | $6.3M | $2.4M | $1.3M | $463.0K | $3.6M | -$2.5M | -$209.0K | -$5.6M | -$3.3M | ||
| Cash And Cash Equivalents At Carrying Value | $7.1M | $1.3M | $896.0K | $4.4M | $106.0K | $1.6M | $90.0K | $94.0K | ||||
| Inventory Net | $2.7M | $2.2M | $175.0K | $145.0K | $121.0K | $144.0K | $76.0K | $67.0K | $71.0K | $35.0K | ||
| Retained Earnings Accumulated Deficit | -$66.1M | -$62.4M | -$56.9M | -$42.7M | -$38.3M | -$32.5M | -$28.4M | -$22.6M | -$19.7M | -$16.9M | ||
| Property Plant And Equipment Net | $7.0K | $7.0K | $5.0K | $4.0K | $4.0K | $8.0K | $5.0K | $11.0K | $10.0K | $18.0K | ||
| Prepaid Expense And Other Assets Current | $154.0K | $712.0K | $230.0K | $267.0K | $268.0K | $95.0K | $61.0K | $42.0K | $86.0K | $19.0K | ||
| Liabilities Current | $2.5M | $2.3M | $1.9M | $2.9M | $409.0K | $640.0K | $797.0K | $565.0K | $297.0K | $5.4M | ||
| Liabilities And Stockholders Equity | $6.7M | $5.9M | $8.6M | $8.2M | $2.0M | $1.6M | $4.9M | $494.0K | $2.0M | $723.0K | ||
| Assets Current | $6.5M | $5.6M | $8.3M | $8.0M | $1.8M | $1.2M | $4.5M | $221.0K | $1.8M | $165.0K | ||
| Assets | $6.7M | $5.9M | $8.6M | $8.2M | $2.0M | $1.6M | $4.9M | $494.0K | $2.0M | $723.0K | ||
| Accounts Payable Current | $138.0K | $66.0K | $87.0K | $144.0K | $129.0K | $193.0K | $168.0K | $82.0K | $58.0K | $101.0K | ||
| Severance Assets Noncurent | $174.0K | $179.0K | $207.0K | $199.0K | $194.0K | $342.0K | $338.0K | $257.0K | $197.0K | $182.0K | ||
| Other Accrued Liabilities Noncurrent | $217.0K | $223.0K | $253.0K | $245.0K | $279.0K | $477.0K | $434.0K | $349.0K | $199.0K | $185.0K | ||
| Accounts Receivable Net Current | $318.0K | $9.0K | $200.0K | $25.0K | $111.0K | $95.0K | $24.0K | $6.0K | $5.0K | $21.0K | ||
| Common Stock Value | $2.0K | $2.0K | $1.0K | $22.0K | $5.0K | $4.0K | $4.0K | $2.0K | $2.0K | |||
| Assets Noncurrent | $187.0K | $270.0K | $280.0K | $259.0K | $198.0K | $350.0K | $344.0K | $273.0K | $207.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $7.7M | $7.5M | $1.3M | $896.0K | $4.4M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.5M | $570.0K | -$5.0M | $204.0K | $6.2M | $442.0K | -$3.5M | |||||
| Liabilities | $2.7M | $2.6M | $2.3M | $5.8M | $688.0K | $1.1M | ||||||
| Other Accounts Payable And Accrued Liabilities | $2.3M | $2.1M | $1.7M | $488.0K | $280.0K | $447.0K | ||||||
| Liabilities Noncurrent | $1.2M | $2.4M | $1.9M | $919.0K | ||||||||
| Accounts Payable Other Current | $629.0K | $483.0K | $239.0K | $702.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$3.5M | $4.3M | -$1.5M | $1.5M | -$4.0K | |||||||
| Operating Lease Right Of Use Asset | $5.0K | $81.0K | $49.0K | $31.0K | ||||||||
| Operating Lease Liability Current | $5.0K | $81.0K | $49.0K | $13.0K | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$67.0K | -$18.0K | $60.0K | $66.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.7M | |||||||||||
| Other Assets Noncurrent | $1.0K | $3.0K | $19.0K | $25.0K | ||||||||
| Deferred Income Noncurrent | $15.0K | $107.0K | $153.0K | $199.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $42.5M | $40.5M | $35.7M | $627.0K | $1.9M | $2.8M | $3.5M | $4.0M | $4.7M | $1.2M | $2.2M | $3.2M | $4.1M | $5.3M | $8.7M | $4.2M | $4.3M | $3.3M | -$784.0K | $498.0K | $2.2M | $1.9M | -$469.0K | $463.0K | $1.4M | $2.2M | $3.0M | $3.6M | -$4.3M | -$3.1M | -$2.8M | -$1.6M | -$1.2M | -$606.0K | -$209.0K | $505.0K | $1.5M | $229.0K | -$4.9M | -$4.2M | ||
| Cash And Cash Equivalents At Carrying Value | $7.0M | $4.0M | $752.0K | $1.3M | $6.0M | $7.7M | $8.6M | $5.7M | $8.0M | $3.2M | $93.0K | $2.3M | $2.4M | $184.0K | $1.7M | $2.5M | $3.5M | $82.0K | $215.0K | $51.0K | $532.0K | $799.0K | $1.3M | $2.0M | $2.3M | $2.8M | $38.0K | $106.0K | ||||||||||||||
| Inventory Net | $2.2M | $2.2M | $2.0M | $2.2M | $2.3M | $2.4M | $2.6M | $3.2M | $3.1M | $2.2M | $1.6M | $928.0K | $355.0K | $201.0K | $205.0K | $173.0K | $109.0K | $111.0K | $104.0K | $102.0K | $141.0K | $134.0K | $78.0K | $78.0K | $91.0K | $82.0K | $60.0K | $63.0K | $59.0K | $76.0K | $74.0K | $53.0K | ||||||||||
| Retained Earnings Accumulated Deficit | -$76.9M | -$76.0M | -$72.3M | -$69.8M | -$68.4M | -$67.4M | -$66.7M | -$65.3M | -$64.6M | -$63.5M | -$60.3M | -$59.4M | -$58.1M | -$54.5M | -$47.8M | -$47.6M | -$41.7M | -$39.3M | -$37.1M | -$36.3M | -$35.2M | -$31.3M | -$30.0M | -$29.2M | -$26.7M | -$25.1M | -$24.3M | -$21.4M | -$20.8M | -$20.2M | -$19.0M | -$17.9M | ||||||||||
| Property Plant And Equipment Net | $124.0K | $112.0K | $125.0K | $9.0K | $9.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $8.0K | $7.0K | $5.0K | $6.0K | $5.0K | $5.0K | $2.0K | $3.0K | $5.0K | $6.0K | $6.0K | $10.0K | $8.0K | $6.0K | $7.0K | $8.0K | $10.0K | $12.0K | $14.0K | $15.0K | $12.0K | $14.0K | ||||||||||
| Prepaid Expense And Other Assets Current | $540.0K | $511.0K | $881.0K | $290.0K | $242.0K | $296.0K | $297.0K | $170.0K | $176.0K | $782.0K | $1.2M | $1.2M | $911.0K | $597.0K | $671.0K | $180.0K | $161.0K | $225.0K | $310.0K | $177.0K | $57.0K | $130.0K | $159.0K | $29.0K | $80.0K | $47.0K | $44.0K | $71.0K | $123.0K | $54.0K | $77.0K | $98.0K | ||||||||||
| Liabilities Current | $11.6M | $6.5M | $8.2M | $2.7M | $2.5M | $2.6M | $2.4M | $2.4M | $2.4M | $2.3M | $1.7M | $2.1M | $2.0M | $266.0K | $391.0K | $876.0K | $364.0K | $352.0K | $522.0K | $865.0K | $702.0K | $582.0K | $511.0K | $583.0K | $933.0K | $754.0K | $631.0K | $403.0K | $317.0K | $329.0K | $270.0K | $265.0K | ||||||||||
| Liabilities And Stockholders Equity | $54.4M | $51.5M | $44.1M | $3.6M | $4.7M | $5.7M | $6.2M | $7.4M | $3.8M | $4.8M | $5.2M | $6.5M | $7.7M | $9.7M | $6.8M | $8.6M | $4.1M | $1.1M | $3.1M | $3.1M | $817.0K | $2.4M | $3.2M | $4.0M | $809.0K | $757.0K | $446.0K | $924.0K | $1.2M | $1.7M | $2.4M | $2.6M | ||||||||||
| Assets Current | $10.0M | $6.9M | $3.9M | $3.3M | $4.4M | $5.4M | $5.9M | $7.2M | $3.6M | $4.6M | $5.0M | $6.3M | $7.4M | $9.4M | $6.6M | $8.4M | $3.9M | $914.0K | $2.8M | $2.9M | $452.0K | $2.1M | $2.8M | $3.6M | $282.0K | $347.0K | $159.0K | $677.0K | $988.0K | $1.4M | $2.2M | $2.4M | ||||||||||
| Assets | $54.4M | $51.5M | $44.1M | $3.6M | $4.7M | $5.7M | $6.2M | $7.4M | $3.8M | $4.8M | $5.2M | $6.5M | $7.7M | $9.7M | $6.8M | $8.6M | $4.1M | $1.1M | $3.1M | $3.1M | $817.0K | $2.4M | $3.2M | $4.0M | $809.0K | $757.0K | $446.0K | $924.0K | $1.2M | $1.7M | $2.4M | $2.6M | ||||||||||
| Accounts Payable Current | $492.0K | $270.0K | $149.0K | $47.0K | $25.0K | $92.0K | $37.0K | $62.0K | $33.0K | $45.0K | $41.0K | $173.0K | $172.0K | $62.0K | $181.0K | $102.0K | $89.0K | $227.0K | $186.0K | $343.0K | $230.0K | $143.0K | $76.0K | $40.0K | $357.0K | $223.0K | $123.0K | $69.0K | $28.0K | $43.0K | $39.0K | $39.0K | ||||||||||
| Severance Assets Noncurent | $190.0K | $186.0K | $171.0K | $173.0K | $170.0K | $167.0K | $171.0K | $165.0K | $170.0K | $179.0K | $178.0K | $184.0K | $207.0K | $199.0K | $198.0K | $193.0K | $163.0K | $204.0K | $218.0K | $207.0K | $359.0K | $350.0K | $339.0K | $343.0K | $298.0K | $292.0K | $272.0K | $235.0K | $235.0K | $217.0K | $190.0K | $192.0K | ||||||||||
| Other Accrued Liabilities Noncurrent | $260.0K | $232.0K | $213.0K | $216.0K | $212.0K | $209.0K | $214.0K | $206.0K | $212.0K | $223.0K | $222.0K | $225.0K | $253.0K | $243.0K | $241.0K | $236.0K | $228.0K | $271.0K | $318.0K | $307.0K | $498.0K | $457.0K | $442.0K | $438.0K | $399.0K | $393.0K | $370.0K | $237.0K | $237.0K | $231.0K | $192.0K | $194.0K | ||||||||||
| Accounts Receivable Net Current | $252.0K | $115.0K | $358.0K | $98.0K | $580.0K | $489.0K | $360.0K | $32.0K | $71.0K | $58.0K | $226.0K | $262.0K | $134.0K | $28.0K | $36.0K | $26.0K | $103.0K | $135.0K | $175.0K | $239.0K | $70.0K | $70.0K | $70.0K | $23.0K | $29.0K | $3.0K | $4.0K | $11.0K | $7.0K | $11.0K | $6.0K | $14.0K | ||||||||||
| Common Stock Value | $1.0K | $8.0K | $1.0K | $1.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $28.0K | $28.0K | $28.0K | $27.0K | $24.0K | $24.0K | $12.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | ||||||||||
| Assets Noncurrent | $44.4M | $44.6M | $40.2M | $298.0K | $305.0K | $310.0K | $290.0K | $193.0K | $217.0K | $246.0K | $221.0K | $233.0K | $273.0K | $241.0K | $248.0K | $246.0K | $198.0K | $207.0K | $223.0K | $218.0K | $365.0K | $364.0K | $351.0K | $354.0K | $527.0K | $410.0K | $287.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.7M | $3.3M | $3.8M | $253.0K | $1.5M | $2.7M | $2.0M | $3.9M | $6.0M | $8.6M | $5.7M | $8.0M | $3.5M | $202.0K | $443.0K | $2.3M | $184.0K | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$151.0K | -$583.0K | -$1.2M | -$1.7M | $445.0K | -$895.0K | -$712.0K | -$869.0K | ||||||||||||||||||||||||||||||||||
| Liabilities | $11.9M | $11.0M | $8.4M | $3.0M | $2.8M | $2.9M | $2.7M | $2.7M | $2.7M | $2.6M | $2.1M | $2.4M | $2.4M | $955.0K | $2.7M | $4.3M | $835.0K | $623.0K | $840.0K | $1.2M | $1.3M | |||||||||||||||||||||
| Other Accounts Payable And Accrued Liabilities | $4.3M | $4.2M | $4.1M | $2.6M | $2.4M | $2.4M | $2.3M | $2.3M | $2.3M | $2.2M | $1.6M | $1.8M | $1.7M | $194.0K | $147.0K | $257.0K | $261.0K | $125.0K | ||||||||||||||||||||||||
| Liabilities Noncurrent | $318.0K | $307.0K | $584.0K | $477.0K | $1.0M | $442.0K | $438.0K | $4.2M | $3.1M | $2.6M | $2.1M | $2.1M | $1.9M | $1.6M | $892.0K | |||||||||||||||||||||||||||
| Accounts Payable Other Current | $286.0K | $522.0K | $321.0K | $447.0K | $439.0K | $435.0K | $543.0K | $576.0K | $531.0K | $508.0K | $334.0K | $289.0K | $286.0K | $231.0K | $226.0K | |||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$869.0K | -$55.0K | -$336.0K | $2.7M | ||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $125.0K | $145.0K | $161.0K | $116.0K | $126.0K | $133.0K | $110.0K | $19.0K | $37.0K | $55.0K | $28.0K | $33.0K | $44.0K | $20.0K | $22.0K | $25.0K | ||||||||||||||||||||||||||
| Operating Lease Liability Current | $112.0K | $81.0K | $148.0K | $52.0K | $49.0K | $44.0K | $24.0K | $19.0K | $37.0K | $55.0K | $28.0K | $33.0K | $44.0K | $10.0K | $10.0K | $11.0K | ||||||||||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$87.0K | -$85.0K | -$81.0K | -$80.0K | -$75.0K | -$73.0K | -$70.0K | -$54.0K | -$55.0K | -$25.0K | $3.0K | $9.0K | $54.0K | $59.0K | $59.0K | $61.0K | ||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $7.0M | $4.1M | $601.0K | $752.0K | $1.3M | $2.2M | $2.7M | $3.3M | $3.8M | $253.0K | $2.3M | $2.4M | $184.0K | $896.0K | $1.7M | $2.5M | $3.5M | $4.4M | ||||||||||||||||||||||||
| Other Assets Noncurrent | $1.0K | $1.0K | $2.0K | $3.0K | $5.0K | $7.0K | $9.0K | $17.0K | $16.0K | $23.0K | $23.0K | $33.0K | ||||||||||||||||||||||||||||||
| Deferred Income Noncurrent | $1.0K | $4.0K | $73.0K | $84.0K | $96.0K | $119.0K | $130.0K | $142.0K | $165.0K | $176.0K | $188.0K | $215.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $1.0K | $4.2M | $2.1M | $4.6M | $9.5M | $4.3M | $94.0K | $6.4M | $33.0K | $3.0M | $900.0K |
| Investing Cash Flow * | -$3.0K | -$1.0K | -$3.0K | -$3.0K | -$2.0K | -$8.0K | -$8.0K | -$1.0K | -$4.0K | ||
| Operating Cash Flow * | -$2.5M | -$3.6M | -$7.0M | -$4.4M | -$3.4M | -$3.9M | -$3.6M | -$2.2M | -$1.5M | -$1.5M | -$900.0K |
| Share Based Compensation | $356.0K | $293.0K | $354.0K | $382.0K | $376.0K | $1.8M | $889.0K | $800.0K | $508.0K | $220.0K | $24.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $356.0K | $293.0K | $190.0K | $190.0K | $376.0K | $713.0K | $889.0K | $800.0K | $459.0K | $220.0K | $24.0K |
| Increase Decrease In Inventories | -$541.0K | $557.0K | $2.0M | $30.0K | $26.0K | -$23.0K | $68.0K | $9.0K | -$4.0K | $36.0K | -$31.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $136.0K | -$558.0K | $482.0K | -$37.0K | -$1.0K | $173.0K | $34.0K | $14.0K | -$44.0K | $67.0K | -$33.0K |
| Increase Decrease In Accounts Receivable | -$221.0K | $309.0K | -$191.0K | $175.0K | -$86.0K | $16.0K | $71.0K | $18.0K | $1.0K | -$16.0K | $8.0K |
| Payments To Acquire Property Plant And Equipment | $3.0K | $1.0K | $3.0K | $3.0K | $2.0K | $8.0K | $8.0K | $1.0K | $4.0K | ||
| Increase Decrease In Accounts Payable Trade | -$91.0K | $72.0K | -$21.0K | -$59.0K | $16.0K | -$64.0K | $25.0K | $86.0K | $24.0K | -$43.0K | $83.0K |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $242.0K | -$18.0K | $78.0K | -$265.0K | $209.0K | -$167.0K | -$182.0K | ||||
| Proceeds From Issuance Or Sale Of Equity | $785.1M | $310.4M | $1.4M | $0.00 | $3.0M | $0.00 | |||||
| Depreciation Depletion And Amortization | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $6.0K | ||||
| Increase Decrease In Other Accounts Payable | -$182.0K | $183.0K | $244.0K | -$105.0K | $183.0K | ||||||
| Increase Decrease In Deferred Revenue | -$46.0K | -$67.0K | -$69.0K | -$2.0K | $199.0K | ||||||
| Increase Decrease In Accrued Severance Pay Net | -$1.0K | -$2.0K | -$39.0K | -$50.0K | $43.0K | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$13.0K | -$49.0K | -$78.0K | -$6.0K | $66.0K | ||||||
| Proceeds From Convertible Debt | $3.0K | $33.0K | $0.00 | $900.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $1.1M | $7.0K | $1.4M | $225.0K | $350.0K | $33.0K | $3.0M | ||||||||||||||||||||
| Investing Cash Flow * | $143.0K | -$1.0K | -$1.0K | -$2.0K | -$2.0K | $0.00 | -$7.0K | $0.00 | |||||||||||||||||||
| Operating Cash Flow * | -$1.3M | -$579.0K | -$1.2M | -$1.7M | -$954.0K | -$895.0K | -$937.0K | -$867.0K | -$405.0K | -$362.0K | -$299.0K | ||||||||||||||||
| Share Based Compensation | $107.0K | $67.0K | $86.0K | $109.0K | $71.0K | $111.0K | $1.3M | $498.0K | $168.0K | $109.0K | $147.0K | $536.0K | $351.0K | $163.0K | $65.0K | $65.0K | $10.0K | ||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $36.0K | $66.0K | $67.0K | $116.0K | $83.0K | $86.0K | $35.0K | $35.0K | $44.0K | $183.0K | $72.0K | $71.0K | $110.0K | $111.0K | $293.0K | $498.0K | $59.0K | $109.0K | $351.0K | $0.00 | $10.0K | ||||||
| Increase Decrease In Inventories | -$567.0K | -$144.0K | $38.0K | $180.0K | $28.0K | -$10.0K | $46.0K | -$7.0K | $5.0K | -$6.0K | |||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $336.0K | $143.0K | $70.0K | $681.0K | -$87.0K | -$43.0K | -$87.0K | $2.0K | -$32.0K | -$362.0K | |||||||||||||||||
| Increase Decrease In Accounts Receivable | $228.0K | $42.0K | $49.0K | -$66.0K | $1.0K | $24.0K | -$27.0K | -$2.0K | $6.0K | -$3.0K | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $5.0K | $1.0K | $1.0K | $2.0K | $2.0K | $0.00 | $7.0K | $0.00 | |||||||||||||||||||
| Increase Decrease In Accounts Payable Trade | -$21.0K | -$101.0K | -$21.0K | $85.0K | -$43.0K | $98.0K | $37.0K | -$15.0K | -$12.0K | ||||||||||||||||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $586.0K | $21.0K | $41.0K | $24.0K | -$231.0K | -$155.0K | -$126.0K | ||||||||||||||||||||
| Proceeds From Issuance Or Sale Of Equity | $225.0K | $350.0K | $0.00 | $3.0M | |||||||||||||||||||||||
| Depreciation Depletion And Amortization | $18.0K | $1.0K | $1.0K | $1.0K | $2.0K | ||||||||||||||||||||||
| Increase Decrease In Other Accounts Payable | -$126.0K | $23.0K | $47.0K | -$357.0K | |||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | -$11.0K | -$11.0K | -$32.0K | -$11.0K | $105.0K | ||||||||||||||||||||||
| Increase Decrease In Accrued Severance Pay Net | -$1.0K | -$3.0K | -$18.0K | $4.0K | |||||||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$1.0K | -$3.0K | -$7.0K | -$6.0K | -$5.0K | ||||||||||||||||||||||
| Proceeds From Convertible Debt | $0.00 | $33.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$13.73 | -$23.32 | -$3.84 | -$0.57 | -$0.42 | -$0.83 | -$0.64 | -$1.17 | -$0.62 | -$0.82 | -$17.08 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 25.2M | 10.3M | 6.9M | 6.4M | 5.0M | 4.6M | 3.5M | 155.0K | |||
| Common Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 24.1M | 20.0M | 24.0M | 20.0M | 20.0M | 20.0M | 24.0M | |
| Common Stock Shares Outstanding | 186.0K | 1.6M | 1.4M | 21.2M | 4.2M | 3.8M | 3.9M | 2.6M | 2.6M | 163.6K | |
| Common Stock Shares Issued | 186.0K | 1.6M | 1.4M | 21.2M | 4.2M | 3.8M | 3.9M | 2.6M | 2.6M | 163.6K | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 269.8K | 159.1K | 1.4M | 1.3M | |||||||
| Earnings Per Share Basic | $-13.73 | $-23.32 | $-3.84 | $-11.35 | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 269.8K | 159.1K | 1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.91 | -$1.03 | $3.98 | -$3.56 | -$27.18 | $2.38 | -$0.42 | -$0.65 | -$0.67 | -$0.68 | -$0.93 | -$0.26 | -$0.01 | -$0.20 | -$0.10 | -$0.20 | -$0.13 | -$0.12 | -$0.16 | -$0.40 | -$0.21 | -$0.13 | -$0.12 | -$0.35 | -$0.18 | -$0.37 | -$0.13 | -$0.13 | -$0.11 | -$0.23 | -$0.10 | -$0.85 | -$4.94 | -$3.73 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.1M | 24.8M | 24.2M | 9.3M | 7.3M | 7.3M | 7.1M | 6.8M | 6.7M | 6.4M | 6.4M | 6.4M | 4.6M | 4.6M | 4.6M | 4.6M | 4.6M | 4.6M | 4.6M | 4.2M | 741.7K | 155.0K | 155.0K | |||||||||||||
| Common Stock Shares Authorized | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 40.0M | 24.1M | 24.1M | 20.0M | 24.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 24.0M | 24.0M | 24.0M | 24.0M | 20.0M | 20.0M | 24.0M | 24.0M | 24.0M | ||||
| Common Stock Shares Outstanding | 1.0M | 787.4K | 734.0K | 37.9K | 2.8M | 2.8M | 2.8M | 1.8M | 1.7M | 1.7M | 28.0M | 28.0M | 28.0M | 27.2M | 24.1M | 24.1M | 12.5M | 4.3M | 4.4M | 4.1M | 4.1M | 4.0M | 4.0M | 3.9M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | ||||
| Common Stock Shares Issued | 1.0M | 787.4K | 734.0K | 37.9K | 2.8M | 2.8M | 2.8M | 1.8M | 1.7M | 1.7M | 28.0M | 28.0M | 28.0M | 27.2M | 24.1M | 24.1M | 12.5M | 4.3M | 4.4M | 4.1M | 4.1M | 4.0M | 4.0M | 3.9M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 858.4K | 484.6K | 626.2K | 280.3K | 25.3K | 247.0K | 1.7M | 1.7M | 1.7M | 1.4M | 1.4M | 1.4M | 26.1M | 24.8M | 24.2M | |||||||||||||||||||||
| Earnings Per Share Basic | $-0.91 | $-1.03 | $-3.56 | $-27.18 | $2.38 | $-0.42 | $-0.65 | $-0.67 | $-0.68 | $-0.93 | $-0.81 | $-0.26 | $-0.01 | $-0.20 | ||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 858.4K | 484.6K | 626.2K | 280.3K | 25.3K | 247.0K | 1.7M | 1.7M | 1.7M | 1.4M | 1.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $70.1M | $65.6M | $63.2M | $45.0M | $39.7M | $33.0M | $32.0M | $20.1M | $19.5M | $11.2M |
| Depreciation | $6.0K | $5.0K | $7.0K | $9.0K | $9.0K | |||||
| Fair Value Adjustment Of Warrants | $549.0K | $383.0K | $962.0K | $138.0K | ||||||
| Stock Issued During Period Value New Issues | $4.2M | $2.1M | $4.2M | $3.6M | $511.0K | |||||
| Stock Issued During Period Value Stock Options Exercised | $7.0K | $2.0K | $3.0K | $33.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $119.4M | $116.5M | $108.1M | $70.5M | $70.3M | $70.3M | $70.3M | $70.0M | $65.8M | $65.7M | $63.4M | $63.5M | $63.2M | $63.1M | $51.9M | $51.8M | $44.9M | $39.7M | $39.4M | $38.2M | $34.7M | $32.7M | $32.2M | $32.1M | $22.4M | $22.1M | $21.5M | $19.8M | $19.7M | $19.6M | $19.5M | $19.4M | |
| Depreciation | $2.0K | $1.0K | $2.0K | $2.0K | |||||||||||||||||||||||||||||
| Fair Value Adjustment Of Warrants | $623.0K | $35.0K | $1.0K | -$25.0K | |||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $1.9M | $3.0K | $4.2M | $420.0K | $3.2M | $511.0K | |||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $107.0K | $7.0K | $3.6M | $33.0K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.